Research Article

[Retracted] Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma

Table 4

Comparison of miRNA cytokine levels between the two groups ().

GroupmiRNA-124miRNA-21miRNA-203
Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatment

Observation group ()5aaa
Control group ()aaa
0.1633.0580.2812.4780.2049.544
0.8710.0030.7790.0150.839<0.001

Note: compared with before treatment in the same group, a.